Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, December 17, 2024
BioCentriq has entered into a long-term lease agreement with National Business Parks for a state-of-the-art cell therapy manufacturing facility in Princeton, New Jersey. The facility will serve as the company's new headquarters and will include an ...
read more
Tuesday, December 17, 2024
RTI Surgical has unveiled its new corporate identity as Evergen, signaling its evolution into a Contract Development and Manufacturing Organization (CDMO) providing biosolutions in regenerative medicine.
read more
Tuesday, December 17, 2024
MediPharm Labs Corp. and Kensana Health Inc. have entered into a share purchase agreement for the purchase and sale of MediPharm's facility in Napanee, Ontario for $5.5 million in cash.
read more
Tuesday, December 17, 2024
BioVaxys Technology Corp. announced that in anticipation of restarting clinical studies of various DPX formulations and initiating new preclinical studies, it has acquired a 48-kilogram ("kg") supply of GMP-grade lipid to enable production of the ...
read more
Thursday, December 12, 2024
Lindus Healthhas launched their “all-in-one” contract research organization (CRO), site, and technology offering bespoke to the unique needs of cardiovascular clinical trials.
read more
Thursday, December 12, 2024
SK pharmteco announced the launch of a brand unification initiative. This strategic move brings together the expertise and capabilities of several industry-respected organizations under the unified SK pharmteco brand.
read more
Thursday, December 12, 2024
Conduit Pharmaceuticals Inc. announced that it has entered into an agreement with SARBORG Limited to leverage an advanced artificial intelligence (AI) and cybernetics platform to evaluate key deliverables across multiple areas of the Company’s ...
read more
Thursday, December 12, 2024
Almac Clinical Technologies, a member of the Almac Group, announced the acquisition of Your Research, a Netherlands-based clinical trial software company.
read more
Tuesday, December 10, 2024
Matica Biotechnology has announced a strategic partnerships with Treovir that aims to advance innovative therapies for pediatric patients with brain and other neurological cancers. Matica Bio will provide GMP manufacturing for clinical supplies.
read more
Tuesday, December 10, 2024
Dotmatics® and Databricks announced a strategic partnership to advance scientific discovery by leveraging the Dotmatics Luma™ Scientific Intelligence Platform.
read more
Tuesday, December 10, 2024
NorthStar Medical Radioisotopes, LLC, and PeptiDream Inc. announced that PeptiDream’s wholly owned subsidiary PDRadiopharma Inc. has entered into a strategic collaboration with NorthStar for the development, production, and commercialization of ...
read more
Tuesday, December 10, 2024
Cellipont Bioservices and Xiogenix have announced a strategic partnership that enables Cellipont Bioservices to offer its clients access to the state-of-the-art Ares™ X20 fill and finish system, significantly enhancing the precision and efficiency of...
read more
Thursday, December 05, 2024
Unlearn®, an artificial intelligence company, announced a partnership with German-based APST Research (APST), a platform for ALS clinical research.
read more
Thursday, December 05, 2024
Charles River Laboratories International, Inc. announced the launch of the Charles River Incubator Program (CIP), specializing in supporting early-stage biotechnology companies in the discovery, development and phase-appropriate manufacturing of ...
read more
Thursday, December 05, 2024
Cambrex, announced that it has signed an agreement with Eli Lilly and Company (Lilly) to deliver accelerated access to clinical development capabilities for Lilly's biotech collaborators.
read more